CP-101,606, a potent neuroprotectant selective for forebrain neurons

European Journal of Pharmacology

Volumn 331, Issue 2-3, 1997, Pages 117-126

  Menniti, Frank ^a   Chenard, Bertrand ^a   Collins, Mary ^a   Ducat, Mary ^a   Shalaby, Ismail ^a   White, Frost ^a  

^a PFIZER INC   (United States)

Author keywords

Neurodegenerative disease; Neurotoxicity; NMDA receptor antagonist

Indexed keywords

GLUTAMIC ACID; IFENPRODIL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; TRAXOPRODIL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING SITE; BRAIN PROTECTION; DEGENERATIVE DISEASE; DRUG RECEPTOR BINDING; FOREBRAIN; HIPPOCAMPUS; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; AUTORADIOGRAPHY; BINDING SITES; CELLS, CULTURED; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; GLUTAMIC ACID; GLYCINE; KINETICS; NEURONS; NEUROPROTECTIVE AGENTS; PIPECOLIC ACIDS; PIPERIDINES; PROSENCEPHALON; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; STEREOISOMERISM;

EID: 0030839993     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)10092-9     Document Type: Article

References (51)

1. 2+ channels and in gerbil global cerebral ischaemia. Eur. J. Pharmacol. 299, 103.
2. 3H]ifenprodil binding sites in the mouse brain. J. Pharmacol. Exp. Ther. 260, 896.
3. Bennett, D.A., Lehmann, J., Bernard, P.S., Liebman, J.M., Williams, M., Wood, P.L., Boast, C.A., Hutchison, A.J., 1990. CGS 19755: a novel competitive N-methyl-D-aspartate (NMDA) receptor antagonist with anticonvulsant, anxiolytic and anti-ischemic properties. Prog. Clin. Biol. Res. 361, 519.
4. 2+ channels in rat cultured cortical neurons. Eur. J. Pharmacol. 257, 297.
5. 2+ channels by the NMDA receptor antagonist eliprodil in acutely dissociated rat Purkinje cells. Eur. J. Pharmacol. 294, 91.
6. Bullock, R., Kuroda, Y., Teasdale, G.M., McCulloch, J., 1992. Prevention of post-traumatic excitotoxic brain damage with NMDA antagonist drugs: a new strategy for the nineties. Acta Neurochir. 55, 49.
7. Carter, C., Benavides, J., Legendre, P., Vincent, J.D., Noel, F., Thuret, F., Lloyd, K.G., Arbilla, S., Zivkovic, B., MacKenzie, E.T. et al., 1988. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents II. Evidence for N-methyl-D-aspartate receptor antagonist properties. J. Pharmacol. Exp. Ther. 247, 1222.
8. Carter, C.J., Lloyd, K.G., Zivkovic, B., Scatton, B., 1990. Ifenprodil and SL 82.0715 as cerebral antiischemic agents III. Evidence for antagonistic effects at the polyamine modulatory site within the N-methyl-D-aspartate receptor complex. J. Pharmacol. Exp. Ther. 253, 475.
9. Chazot, P.L., Coleman, S.K., Cik, M., Stephenson, F.A., 1994. Molecular characterization of N-methyl-D-aspartate receptors expressed in mammalian cells yields evidence for the coexistence of three subunit types within a discrete receptor molecule. J. Biol. Chem. 269, 24403.
10. Chenard, B.L., Bordner, J., Butler, T.W., Chambers, L.K., Collins, M.A., Decosta, D.L., Ducat, M.F., Dumont, M.L., Fox, C.B., Mena, E.E., Menniti, F.S., Nielsen, J., Pagnozzi, M.J., Richter, K.E.G., Ronau, R.T., Shalaby, I.A., Stemple, J.Z., White, W.F., 1995. (1S,2S)-1-(4-Hydroxyphenyl)-2-(4-hydroxy-4- phenylpiperidino)-1-propanol: a potent new neuroprotectant which blocks N-methyl-D-aspartate responses. J. Med. Chem. 38, 3138.
11. Choi, D.W., Koh, J.Y., Peters, S., 1988. Pharmacology of glutamate neurotoxicity in cortical cell culture: attenuation by NMDA antagonists. J. Neurosci. 8, 185.
12. 3H](+)-3-PPP to sigma binding sites in rat brain. Neurosci. Lett. 116, 190.
13. 3H]ifenprodil binding sites in the rat brain. Neurosci. Lett. 125, 45.
14. Gallagher, M.J., Huang, H., Pritchett, D.B., Lynch, D.R., 1996. Interactions between ifenprodil and the NR2B subunit of the N-methyl-D-aspartate receptor. J. Biol. Chem. 271, 9603.
15. Gotti, B., Duverger, D., Bertin, J., Carter, C., Dupont, R., Frost, J., Gaudilliere, B., MacKenzie, E.T., Rousseau, J., Scatton, B., 1988. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents I. Evidence for efficacy in models of focal cerebral ischemia. J. Pharmacol. Exp. Ther. 247, 1211.
16. Graham, D., Darles, G., Langer, S.Z., 1992. The neuroprotective proper-ties of ifenprodil, a novel NMDA receptor antagonist, in neuronal cell culture toxicity studies. Eur. J. Pharmacol. 226, 373.
17. Greenamyre, J.T., 1986. The role of glutamate in neurotransmission and in neurologic disease. Arch. Neurol. 43, 1058.
18. Hargreaves, R.J., Hill, R.G., Iversen, L.L., 1994. Neuroprotective NMDA antagonists: the controversy over their potential for adverse effects on cortical neuronal morphology. Acta Neurochir. 60 (Suppl.), 15.
19. 3H]ifenprodil binding to sigma receptors in rat brain. Eur. J. Pharmacol. 236, 159.
20. 3H]ifenprodil binding in rat brain. Eur. J. Pharmacol. 266, 67.
21. Ishii, T., Moriyoshi, K., Sugihara, H., Sakurada, K., Kadotani, H., Yokoi, M., Akazawa, C., Shigemoto, R., Mizuno, N., Masu, M., 1993. Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits. J. Biol. Chem. 268, 2836.
22. Johnson, J.W., Ascher, P., 1987. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 325, 529.
23. 3H](+)-3-PPP-labeled sigma binding sites in guinea pig brain membranes. Eur. J. Pharmacol. 176, 247.
24. Kemp, J.A., Leeson, P.D., 1993. The glycine site of the NMDA receptor - five years on. Trends Pharmacol. Sci. 14, 20.
25. Kemp, J.A., Foster, A.C., Wong, E.H.F., 1987. Non-competitive antagonists of excitatory amino acid receptors. Trends Neurosci. 10, 294.
26. Koh, J.Y., Choi, D.W., 1987. Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J. Neurosci. Methods 20, 83.
27. Kutsuwada, T., Kashiwabuchi, N., Mori, H., Sakimura, K., Kushiya, E., Araki, K., Meguro, H., Masaki, H., Kumanishi, T., Arakawa, M., Mishina, M., 1992. Molecular diversity of the NMDA receptor channel. Nature 358, 36.
28. Leeson, P.D., Iversen, L.L., 1994. The glycine site on the NMDA receptor: structure-activity relationships and therapeutic potential. J. Med. Chem. 37, 4053.
29. Lowe, D.A., Emre, M., Frey, P., Kelly, P.H., Malanowski, J., Mcallister, K.H., Neijt, H.C., Rudeberg, C., Urwyler, S., White, T.G., Herring, P.L., 1994. The pharmacology of SDZ EAA 494, a competitive NMDA antagonist. Neurochem. Int. 25, 583.
30. Maragos, W.F., Greenamyre, J.T., Penney, J.B., Young, A.B., 1987. Glutamate dysfunction in Alzheimer's disease: an hypothesis. Trends Neurosci. 10, 65.
31. McCulloch, J., 1994. Glutamate receptor antagonists in cerebral ischaemia. J. Neural Transm. 71.
32. Menniti, F.S., Collins, M.A., Chenard, B.L., Shalaby, I.A., White, W.F., 1995. CP-101,606, a potent and selective antagonist of forebrain NMDA receptors: in vitro neuroprotective activity. Soc. Neurosci. Abstr. 21 (Suppl. Part 1-3).
33. Monyer, H., Sprengel, R., Schoepfer, R., Herb, A., Higuchi, M., Lomeli, H., Burnashev, N., Sakmann, B., Seeburg, P.H., 1992. Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science 256, 1217.
34. Monyer, H., Burnashev, N., Laurie, D.J., Sakmann, B., Seeburg, P.H., 1994. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12, 529.
35. Mori, H., Mishina, M., 1995. Structure and function of the NMDA receptor channel. Neuropharmacology 34, 1219.
36. Mosmann, T., 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55.
37. Muir, K.W., Lees, K.R., 1995. Clinical experience with excitatory amino acid antagonist drugs. Stroke 26, 503.
38. 3H]-CGS 19755: a novel N-methyl-D-aspartate antagonist with nanomolar affinity in rat brain. Br. J. Pharmacol. 95, 932.
39. Parks, T.N., Artman, L.D., Alasti, N., Nemeth, E.F., 1991. Modulation of N-methyl-D-aspartate receptor-mediated increases in cytosolic calcium in cultured rat cerebellar granule cells. Brain Res. 552, 13.
40. Paxinos, G., Watson, C., 1986. The Rat Brain in Stereotaxic Coordinates. Academic Press, San Diego.
41. 3H]MK-801 binding to the N-methyl-D-aspartate receptor-ion channel complex by L-glutamate, glycine, and polyamines. J. Neurochem. 51, 830.
42. Reddy, N.L., Hu, L.Y., Cotter, R.E., Fischer, J.B., Wong, W.J., McBurney, R.N., Weber, E., Holmes, D.L., Wong, S.T., Prasad, R. et al., 1994. Synthesis and structure-activity studies of N,N′-diarylguanidine derivatives. N-(1-Naphthyl)-N′-(3-ethylphenyl)-N′-methylguanidine: a new, selective noncompetitive NMDA receptor antagonist. J. Med. Chem. 37, 260.
43. Rosenberg, P.A., Aizenman, E., 1989. Hundred-fold increase in neuronal vulnerability to glutamate toxicity in astrocyte-poor cultures of rat cerebral cortex. Neurosci. Lett. 103, 162.
44. Schmidt, W.J., 1994. Behavioural effects of NMDA-receptor antagonists. J. Neural Transm. 43 (Suppl.), 63.
45. 3H]ifenprodil, a novel NMDA antagonist, to a polyamine-sensitive site in the rat cerebral cortex. Eur. J. Pharmacol. 176, 249.
46. Shalaby, I.A., Chenard, B.L., Prochniak, M.A., Butler, T.W., 1992. Neuroprotective effects of the N-methyl-D-aspartate receptor antagonists ifenprodil and SL-82,0715 on hippocampal cells in culture. J. Pharmacol. Exp. Ther. 260, 925.
47. Toulmond, S., Serrano, A., Benavides, J., Scatton, B., 1993. Prevention by eliprodil (SL-82.0715) of traumatic brain damage in the rat - existence of a large (18-h) therapeutic window. Brain Res. 620, 32.
48. Wenzel, A., Scheurer, L., Kunzi, R., Fritschy, J.M., Mohler, H., Benke, D., 1995. Distribution of NMDA receptor subunit proteins NR2A, 2B, 2C and 2D in rat brain. NeuroReport 7, 45.
49. White, W.F., Ducat, M.F., Chenard, B.L., Butler, T.W., Ronau, R.T., 1995. CP-101,606, a potent and selective antagonist of forebrain NMDA receptors: binding to a novel recognition site. Soc. Neurosci. Abstr. 21 (Suppl. Part 1-3).
50. Williams, K., 1995. Pharmacological properties of recombinant N-methyl-D-aspartate (NMDA) receptors containing the epsilon 4 (NR2D) subunit. Neurosci. Lett. 184, 181.
51. Williams, K., Russell, S.L., Shen, Y.M., Molinoff, P.B., 1993. Developmental switch in the expression of NMDA receptors occurs in vivo and in vitro. Neuron 10, 267.